Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10562004Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2024
Linked Award Amount
$592.1K
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#26,880
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing James Christopher Costello as a PI. Multi-PI records show the full award amount for context.
- 5R01CA268055-03R01NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$476.6Kaward amount
- 3R01CA268055-03S1R01NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$81Kaward amount
- $25.4Kaward amount
- 3R01CA268055-02S1R01Investigating NPEPPS-mediated feedback between bladder cancer cells and peripheral neurons as a mechanism of cisplatin resistance$9.2Kaward amount
Award organizations
Organizations that administered FY2024 awards listing James Christopher Costello as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCedars-Sinai Medical Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7778
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as James Christopher Costello.